NRC Health (NRC) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 140.00M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $140.00M | (m) | (m) |
| 2026-03-31 | (m) | $138.64M | (m) | (m) |
| 2025-12-31 | (m) | $137.39M | (m) | (m) |
| 2025-09-30 | (m) | $139.10M | (m) | (m) |
| 2025-06-30 | (m) | $140.31M | (m) | (m) |
| 2025-03-31 | (m) | $141.30M | (m) | (m) |
| 2024-12-31 | (m) | $143.06M | (m) | (m) |
| 2024-09-30 | (m) | $144.16M | (m) | (m) |
| 2024-06-30 | (m) | $146.28M | (m) | (m) |
| 2024-03-31 | (m) | $147.42M | (m) | (m) |
| 2023-12-31 | (m) | $148.58M | (m) | (m) |
| 2023-09-30 | (m) | $148.72M | (m) | (m) |
| 2023-06-30 | (m) | $148.47M | (m) | (m) |
| 2023-03-31 | (m) | $149.60M | (m) | (m) |
| 2022-12-31 | (m) | $151.57M | (m) | (m) |
| 2022-09-30 | (m) | $151.72M | (m) | (m) |
| 2022-06-30 | (m) | $151.80M | (m) | (m) |
| 2022-03-31 | (m) | $150.93M | (m) | (m) |
| 2021-12-31 | (m) | $147.95M | (m) | (m) |
| 2021-09-30 | (m) | $144.43M | (m) | (m) |
| 2021-06-30 | (m) | $140.14M | (m) | (m) |
| 2021-03-31 | (m) | $134.88M | (m) | (m) |
| 2020-12-31 | (m) | $133.28M | (m) | (m) |
| 2020-09-30 | (m) | $131.13M | (m) | (m) |
| 2020-06-30 | (m) | $130.11M | (m) | (m) |
| 2020-03-31 | (m) | $130.36M | (m) | (m) |
| 2019-12-31 | (m) | $127.98M | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $119.69M | (m) | (m) |
| 2017-12-31 | (m) | $117.56M | (m) | (m) |
| 2017-09-30 | (m) | $116.03M | (m) | (m) |
| 2017-06-30 | (m) | $114.11M | (m) | (m) |
| 2017-03-31 | (m) | $111.79M | (m) | (m) |
| 2016-12-31 | (m) | $109.38M | (m) | (m) |
| 2016-09-30 | (m) | $107.38M | (m) | (m) |
| 2016-06-30 | (m) | $105.59M | (m) | (m) |
| 2016-03-31 | (m) | $103.94M | (m) | (m) |
| 2015-12-31 | (m) | $102.34M | (m) | (m) |
| 2015-09-30 | (m) | $101.10M | (m) | (m) |
| 2015-06-30 | (m) | $99.54M | (m) | (m) |
| 2015-03-31 | (m) | $99.08M | (m) | (m) |
| 2014-12-31 | (m) | $98.84M | (m) | (m) |
| 2014-09-30 | (m) | $96.64M | (m) | (m) |
| 2014-06-30 | (m) | $95.36M | (m) | (m) |
| 2014-03-31 | (m) | $93.71M | (m) | (m) |
| 2013-12-31 | (m) | $92.59M | (m) | (m) |
| 2013-09-30 | (m) | $91.66M | (m) | (m) |
| 2013-06-30 | (m) | $90.64M | (m) | (m) |
| 2013-03-31 | (m) | $88.92M | (m) | (m) |
| 2012-12-31 | (m) | $86.42M | (m) | (m) |
| 2012-09-30 | (m) | $83.54M | (m) | (m) |
| 2012-06-30 | (m) | $80.70M | (m) | (m) |
| 2012-03-31 | (m) | $78.38M | (m) | (m) |
| 2011-12-31 | (m) | $75.77M | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $63.40M | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $57.69M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |